CTRI/2013/10/004098进行中（未招募）2 期
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of cerebral palsy in subjects below 15 years. - BMCP2
Arvind Bagul0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subjects aged above 3 years and below 15 years with a diagnosis of Cerebral Palsy.
- •2. Regional nerve damage as shown by Magnetic Resonance Imaging (MRI)
- •3. Able to comprehend and give informed consent for the study and willing to come to the hospital for follow up visits as per the protocol requirements (patient or his legal guardian).
排除标准
- •1. History of meningitis, meningoencephalitis, epilepsy or life ?threatening allergic or immune-mediated reaction
- •2. Hemodynamically unstable patients
- •3. History of or concurrent autoimmune disease or an acute episode of Guillain-barre syndrome
- •4. Peripheral muscular dystrophy
研究者
相似试验
招募中
2 期
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of cerebral palsy in subjects above 15 years.CTRI/2011/091/000159Chaitanya Stem Cell Center100
进行中（未招募）
2 期
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of stroke.CTRI/2013/10/004105Arivind Bagul100
进行中（未招募）
2 期
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of Chronic ParaplegiaCTRI/2013/10/004109Arvind Bagul100
进行中（未招募）
2 期
A clinical trial to study the safety and efficacy of Bone marrow derived autologous cells for the treatment of Acute ParaplegiaCTRI/2013/10/004099Chaitanya Vaidyakiya seva sanstha100
终止
不适用
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusioKCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20